Merck KgAa CFO expect higher costs to prevail in the coming quarters - YouTube

Channel: CNBC International TV

[0]
looking on the global uncertainties
[2]
macroeconomic challenges and of course
[5]
the overall geopolitical situation i
[7]
think it is fair to say that there are
[10]
some
[11]
cautioning remarks also in the guidance
[14]
that if the china lockdown is actually
[16]
going to spread far into the second half
[19]
of the year and if more than just a few
[22]
or a couple of provinces will finally be
[24]
affected that might have an impact on
[27]
our numbers but that is not the current
[29]
scenario of our of our assumptions on
[31]
the other hand when we look on elevated
[34]
um freight logistics cost as well as
[36]
energy costs we think that those costs
[39]
will remain on a high level for the end
[42]
or until the end of the year but at the
[44]
same time we feel well prepared actually
[47]
to counter those cost increases
[49]
with own discipline cost management and
[52]
also selective price increases wherever
[55]
possible
[56]
yeah very interesting marcus the line
[58]
where you when you talk about trying to
[60]
offset
[62]
some of the impact from chinese
[65]
restriction on manufacturing by moving
[67]
to a more e-commerce focused model could
[70]
you just unpack that for us what does
[72]
that actually mean
[75]
yeah that's there's not much rocket
[78]
science behind it we have made i think a
[80]
lot of experiences during the last two
[83]
years when we experienced
[85]
partially hard lockdowns in the kovy
[88]
times you know it started some two years
[90]
ago in asia the second quarter 2020 was
[92]
heavily affected in the us and europe or
[95]
was heavily affecting u.s and europe so
[97]
we made we had a lot of learnings we
[99]
made our experiences and we know that
[102]
those kind of digital go-to-market
[104]
models work we have a well-functioning
[108]
e-commerce platform in life science
[110]
where we already root today a major part
[113]
of our of our sail through so that is i
[116]
would say a natural countermeasure
[119]
that we just
[120]
revitalize in case that the lockdown
[123]
scenario is going more tough
[126]
marcus i just stumbled across a figure
[128]
in the results today a fairly stunning
[130]
26.6
[132]
uh balanced in organic growth i'm sure
[134]
you know what i'm talking about here the
[135]
oncology franchise just give us a sense
[138]
as to why growth is so strong in that
[140]
area and will it continue from here
[143]
um
[144]
so
[145]
there are two components actually which
[147]
have driven this 27 organic increase in
[150]
oncology first and foremost it is our
[153]
new newly launched product bavencio
[156]
which has basically doubled sales
[158]
compared to the first quarter
[160]
2021 so we have seen a 102 percent
[164]
increase here at the same time the
[166]
second contributor was our established
[168]
product abitooks which also grew by
[171]
almost 10 percent organically and here i
[173]
think a major driver was a more recent
[177]
um achievement that we would have been
[179]
entering the nrdl in china with abi
[182]
talks in
[183]
in the indication of
[185]
of head and neck cancer so that was also
[187]
obviously a gross driver if we look
[190]
forward we believe that we will
[192]
continuously see abby talks growing on
[194]
the one hand maybe not 10 every quarter
[197]
but we are confident that we'll see
[199]
further growth going forward and we are
[201]
very optimistic that vavenzio remains a
[205]
gross driver for oncology but also for
[208]
healthcare
[209]
for for the entire sector
[211]
for the next couple of quarters actually
[213]
marcus if we can just dig into the
[215]
electronics business sector it feels as
[218]
though you've got some of the usual
[219]
suspects here that other sectors are
[222]
facing too the margin pressure inflation
[225]
and raw material costs just unpick that
[228]
for us what are you seeing and what you
[230]
anticipate in the coming months
[234]
yeah so the anticipation is actually an
[236]
ongoing pressure on certain p l lines
[239]
from the effects that you rightly
[241]
mentioned so to be a little bit more
[242]
precise in the first quarter we have
[244]
seen elevated raw material prices in
[247]
certain areas which are important for us
[249]
so for example oil based solvents as one
[251]
example
[252]
we have seen at the second or we have
[255]
seen on top of that
[257]
um pretty much elevated freight and
[260]
logistics costs as well as high energy
[263]
costs and actually we expect all these
[266]
developments and factors
[268]
to prevail for the next couple of
[271]
quarters so definitely until year end
[274]
the good news however is that this is
[276]
somewhat baked into our guidance
[279]
so high pricing levels on these input
[281]
costs
[282]
will not come as a surprise and we are
[286]
thinking about a lot of counter measures
[288]
in order actually to safeguard margins
[291]
and to deliver the guidance that you
[292]
have seen today